Literature DB >> 11172200

Acute respiratory distress syndrome and blastomycosis: presentation of nine cases and review of the literature.

L B Lemos1, M Baliga, M Guo.   

Abstract

Mississippi has the highest prevalence of blastomycosis in the country. In 20 years and 5 months there were 123 patients treated for blastomycosis at the University of Mississippi Medical Center. Among these, 107 patients had lung involvement and nine patients (8.4%) developed acute respiratory distress syndrome. Seven of the nine patients (78%) died of respiratory failure. In six patients, the lungs were the only organs involved. The three other patients had involvement of other organs as well. Average survival after the onset of acute respiratory distress syndrome was 6.9 days (range, 2 to 17 days). Acute respiratory distress syndrome can be triggered by pulmonary infections caused by bacterial diseases and other fungi. Massive proliferation of yeasts in the pulmonary parenchyma is the typical finding of patients with blastomycosis and acute respiratory distress syndrome. Underlying diseases that lead to immunodepression were present in only one patient and probable partial immunodepression was present in two other patients. Data from 19 other cases reported in the literature are discussed. Ann Diagn Pathol 5:1-9, 2001. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2001        PMID: 11172200     DOI: 10.1053/adpa.2001.21473

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  15 in total

1.  Primary cutaneous blastomycosis as a cause of acute respiratory distress syndrom: case report and literature review.

Authors:  Jason J Emer; Joel B Spear
Journal:  J Clin Aesthet Dermatol       Date:  2009-03

2.  Cutaneous manifestations of endemic mycoses.

Authors:  Jeannina A Smith; James Riddell; Carol A Kauffman
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

Review 3.  Secondary intracerebral blastomycosis with giant yeast forms.

Authors:  Shou Jin Wu; Tibor Valyi-Nagy; Herbert H Engelhard; Mary Anhthu Do; William M Janda
Journal:  Mycopathologia       Date:  2005-10       Impact factor: 2.574

4.  Pulmonary blastomycosis masquerading as metastatic disease in the lung: a case report.

Authors:  Bobbak Vahid; Bernadette Wildemore; Christopher Nguyen; Niki Sistrun; Paul E Marik
Journal:  MedGenMed       Date:  2006-01-31

Review 5.  Clinical and laboratory update on blastomycosis.

Authors:  Michael Saccente; Gail L Woods
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 6.  How Environmental Fungi Cause a Range of Clinical Outcomes in Susceptible Hosts.

Authors:  Steven T Denham; Morgan A Wambaugh; Jessica C S Brown
Journal:  J Mol Biol       Date:  2019-05-09       Impact factor: 5.469

Review 7.  Clinical Manifestations and Treatment of Blastomycosis.

Authors:  Joseph A McBride; Gregory M Gauthier; Bruce S Klein
Journal:  Clin Chest Med       Date:  2017-06-12       Impact factor: 4.967

8.  Hypercoagulability in dogs with blastomycosis.

Authors:  M A McMichael; M O'Brien; S A Smith
Journal:  J Vet Intern Med       Date:  2015 Mar-Apr       Impact factor: 3.333

9.  Rapid progression of pulmonary blastomycosis in an untreated patient of chronic lymphocytic leukemia.

Authors:  Pralay K Sarkar; Paras Malhotra; P S Sriram
Journal:  Case Rep Med       Date:  2014-04-13

10.  Management and Outcomes of Acute Respiratory Distress Syndrome Caused by Blastomycosis: A Retrospective Case Series.

Authors:  Ilan S Schwartz; John M Embil; Atul Sharma; Stephen Goulet; R Bruce Light
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.